Detection of Minimal Residual Disease in Cerebro-Spinal Fluid of a Patient with Acute Myelogenous Leukemia with t(16 ; 21)(p11 ;q22) Translocation by Reverse Transcriptase-Polymerase Chain Reaction

Hideo Harigae, Masaru Kobayashi, Akio Mihara, Norimichi Watanabe

研究成果: Article

2 引用 (Scopus)

抜粋

We describe a patient with acute myelogenous leukemia (AML) with t(16 ; 21)(p11 ; q22) translocation, whose minimal residual disease (MRD) both in cerebrospinal fluid (CSF) and bone marrow (BM) was monitored by reverse transcriptase-polymerase chain reaction (RT-PCR). A TLS/ERG-FUS fusion transcript, which is known to be expressed by t(16 ; 21)(p11 ; q22) translocation, was detectable by RT-PCR both in BM and CSF cells in the first complete remission, suggesting the existence of MRD. The disease relapsed 6 months after its onset and allogeneic peripheral blood stem cell transplantation (PBSCT) was undergone. A TLS/ERG-FUS fusion transcript became rapidly below the detection level after PBSCT. These findings suggest the usefulness of RT-PCR for the detection of MRD in CSF, which contains a limited number of cells as well as BM.

元の言語English
ページ(範囲)297-302
ページ数6
ジャーナルTohoku Journal of Experimental Medicine
183
発行部数4
DOI
出版物ステータスPublished - 1997 12
外部発表Yes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

フィンガープリント Detection of Minimal Residual Disease in Cerebro-Spinal Fluid of a Patient with Acute Myelogenous Leukemia with t(16 ; 21)(p11 ;q22) Translocation by Reverse Transcriptase-Polymerase Chain Reaction' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用